Bortezomib for Low or Intermediate-1 Myelodysplastic Syndrome (MDS) With p65 Activation
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bortezomib
Related studies linked through entity extraction aliases.
Bortezomib in Late Antibody-mediated Kidney Transplant Rejection
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Proteasomal Inhibition for Patients With Mis-sense Mutated Dysferlin
- Status
- TERMINATED
- Phase
- PHASE1
Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy/Safety Study of R-CHOP vs Bortezomib-R-CAP for Young Patients With Diffuse Large B-cell Lymphoma With Poor IPI.
- Status
- COMPLETED
- Phase
- PHASE2
Desensitization With Bortezomib Before a Living Kidney Donation
- Status
- UNKNOWN
- Phase
- PHASE4
Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12D
- Status
- COMPLETED
- Phase
- PHASE2
WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
A Post-Approval Pharmacokinetic Study of Bortezomib in Participants With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
A Study Evaluating ABT-199 in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM)
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Desensitization Therapy in Sensitized Participants Awaiting Heart Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Bortezomib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD
- Status
- TERMINATED
- Phase
- PHASE1